Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid - Université d'Évry Access content directly
Journal Articles Human Gene Therapy Year : 2019

Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid

No file

Dates and versions

hal-02178315 , version 1 (09-07-2019)

Identifiers

Cite

Alice Moussy, Nan Papili Gao, Guillaume Corre, Valentina Poletti, Saliha Majdoul, et al.. Constraints on Human CD34+ Cell Fate due to Lentiviral Vectors Can Be Relieved by Valproic Acid. Human Gene Therapy, 2019, ⟨10.1089/hum.2019.009⟩. ⟨hal-02178315⟩
44 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More